{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T18:14:18Z","timestamp":1780942458415,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T00:00:00Z","timestamp":1629072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["1I01RX002447-01"],"award-info":[{"award-number":["1I01RX002447-01"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["B9280-O"],"award-info":[{"award-number":["B9280-O"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["IK2RX002781"],"award-info":[{"award-number":["IK2RX002781"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006380","name":"Rehabilitation Research and Development Service","doi-asserted-by":"publisher","award":["2RX002781"],"award-info":[{"award-number":["2RX002781"]}],"id":[{"id":"10.13039\/100006380","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006380","name":"Rehabilitation Research and Development Service","doi-asserted-by":"publisher","award":["9280-O"],"award-info":[{"award-number":["9280-O"]}],"id":[{"id":"10.13039\/100006380","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.coph.2021.07.023","type":"journal-article","created":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T17:42:34Z","timestamp":1630172554000},"page":"193-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Pharmacologic approaches to prevent skeletal muscle atrophy after spinal cord injury"],"prefix":"10.1016","volume":"60","author":[{"given":"Dana M.","family":"Otzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7593-9184","authenticated-orcid":false,"given":"Hui Jean","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6506-7025","authenticated-orcid":false,"given":"Zachary A.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7401-4398","authenticated-orcid":false,"given":"Elisabeth R.","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2727-8649","authenticated-orcid":false,"given":"Joshua F.","family":"Yarrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2021.07.023_bib1","series-title":"National Spinal Cord Injury Statistical Center, facts and figures at a glance","author":"NSCISC","year":"2021"},{"key":"10.1016\/j.coph.2021.07.023_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19061701","article-title":"Activity-based physical rehabilitation with adjuvant testosterone to promote neuromuscular recovery after spinal cord injury","volume":"19","author":"Otzel","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2021.07.023_bib3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1089\/neu.2012.2504","article-title":"Hindlimb muscle morphology and function in a new atrophy model combining spinal cord injury and cast immobilization","volume":"30","author":"Ye","year":"2013","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.coph.2021.07.023_bib4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00424-009-0643-5","article-title":"Differential skeletal muscle gene expression after upper or lower motor neuron transection","volume":"458","author":"Zeman","year":"2009","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.coph.2021.07.023_bib5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00421-018-4039-0","article-title":"Mitochondrial health and muscle plasticity after spinal cord injury","volume":"119","author":"Gorgey","year":"2019","journal-title":"Eur J Appl Physiol"},{"key":"10.1016\/j.coph.2021.07.023_bib6","first-page":"10","article-title":"Pathophysiology, biomarkers, and therapeutic modalities associated with skeletal muscle loss following spinal cord injury","author":"Drasites","year":"2020","journal-title":"Brain Sci"},{"key":"10.1016\/j.coph.2021.07.023_bib7","doi-asserted-by":"crossref","first-page":"E754","DOI":"10.1152\/ajpendo.00240.2015","article-title":"Heightened TWEAK-NF-kappaB signaling and inflammation-associated fibrosis in paralyzed muscles of men with chronic spinal cord injury","volume":"310","author":"Yarar-Fisher","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.coph.2021.07.023_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/mus.21293","article-title":"Atrogin-1, MuRF1, and FoXO, as well as phosphorylated GSK-3beta and 4E-BP1 are reduced in skeletal muscle of chronic spinal cord-injured patients","volume":"40","author":"Leger","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.coph.2021.07.023_bib9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/j.2040-4603.2019.tb00062.x","article-title":"Insulin-like growth factor I regulation and its actions in skeletal muscle","volume":"9","author":"Vassilakos","year":"2018","journal-title":"Comp Physiol"},{"key":"10.1016\/j.coph.2021.07.023_bib10","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1096\/fj.201801653RR","article-title":"The role of raptor in the mechanical load-induced regulation of mTOR signaling, protein synthesis, and skeletal muscle hypertrophy","volume":"33","author":"You","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.coph.2021.07.023_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13051","article-title":"Protein translation, proteolysis and autophagy in human skeletal muscle atrophy after spinal cord injury","volume":"223","author":"Lundell","year":"2018","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.coph.2021.07.023_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203042","article-title":"Effects of ursolic acid on sub-lesional muscle pathology in a contusion model of spinal cord injury","volume":"13","author":"Bigford","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.coph.2021.07.023_sref13","doi-asserted-by":"crossref","first-page":"113064","DOI":"10.1016\/j.expneurol.2019.113064","article-title":"beta2-adrenergic receptor-mediated mitochondrial biogenesis improves skeletal muscle recovery following spinal cord injury","volume":"322","author":"Scholpa","year":"2019","journal-title":"Exp Neurol"},{"key":"10.1016\/j.coph.2021.07.023_bib14","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.apmr.2014.10.021","article-title":"Elevated circulating levels of the pro-inflammatory cytokine macrophage migration inhibitory factor in individuals with acute spinal cord injury","volume":"96","author":"Bank","year":"2015","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.coph.2021.07.023_sref15","doi-asserted-by":"crossref","first-page":"e841","DOI":"10.1212\/WNL.0000000000007998","article-title":"High-dose methylprednisolone for acute traumatic spinal cord injury: a meta-analysis","volume":"93","author":"Liu","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.coph.2021.07.023_sref16","doi-asserted-by":"crossref","DOI":"10.3390\/cells8050406","article-title":"Skeletal muscle response to deflazacort, dexamethasone and methylprednisolone","volume":"8","author":"Fappi","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.coph.2021.07.023_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/sc.2011.91","article-title":"Testosterone reduced methylprednisolone-induced muscle atrophy in spinal cord-injured rats","volume":"50","author":"Wu","year":"2012","journal-title":"Spinal Cord"},{"key":"10.1016\/j.coph.2021.07.023_bib18","first-page":"429","article-title":"Effect of spinal cord injury and related conditions","volume":"vol. 2","author":"Yarrow","year":"2020"},{"key":"10.1016\/j.coph.2021.07.023_bib19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41393-018-0207-7","article-title":"Serum testosterone levels may influence body composition and cardiometabolic health in men with spinal cord injury","volume":"57","author":"Abilmona","year":"2019","journal-title":"Spinal Cord"},{"key":"10.1016\/j.coph.2021.07.023_bib20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1682\/JRRD.2011.04.0076","article-title":"Insulin growth factors may explain relationship between spasticity and skeletal muscle size in men with spinal cord injury","volume":"49","author":"Gorgey","year":"2012","journal-title":"J\u00a0Rehabil Res Dev"},{"key":"10.1016\/j.coph.2021.07.023_bib21","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/jcsm.12291","article-title":"Muscular responses to testosterone replacement vary by administration route: a systematic review and meta-analysis","volume":"9","author":"Skinner","year":"2018","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.coph.2021.07.023_bib22","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/jama.1951.02920260017005","article-title":"Testosterone propionate as a nitrogen-sparing agent after spinal cord injury","volume":"145","author":"Cooper","year":"1951","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.coph.2021.07.023_bib23","doi-asserted-by":"crossref","first-page":"338","DOI":"10.12998\/wjcc.v3.i4.338","article-title":"Review of health risks of low testosterone and testosterone administration","volume":"3","author":"Jia","year":"2015","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.coph.2021.07.023_bib24","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1055\/s-0031-1280797","article-title":"A\u00a0small-scale clinical trial to determine the safety and efficacy of testosterone replacement therapy in hypogonadal men with spinal cord injury","volume":"43","author":"Bauman","year":"2011","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.coph.2021.07.023_bib25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1179\/2045772314Y.0000000206","article-title":"Lean tissue mass and energy expenditure are retained in hypogonadal men with spinal cord injury after discontinuation of testosterone replacement therapy","volume":"38","author":"Bauman","year":"2015","journal-title":"J\u00a0Spinal Cord Med"},{"key":"10.1016\/j.coph.2021.07.023_sref26","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1089\/neu.2018.6136","article-title":"Low-dose testosterone and evoked resistance exercise after spinal cord injury on cardio-metabolic risk factors: an open-label randomized clinical trial","volume":"36","author":"Gorgey","year":"2019","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.coph.2021.07.023_sref27","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1152\/japplphysiol.00865.2019","article-title":"Sixteen weeks of testosterone with or without evoked resistance training on protein expression, fiber hypertrophy and mitochondrial health after spinal cord injury","volume":"128","author":"Gorgey","year":"2020","journal-title":"J\u00a0Appl Physiol"},{"key":"10.1016\/j.coph.2021.07.023_sref28","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/jnr.24564","article-title":"Locomotor training with adjuvant testosterone preserves cancellous bone and promotes muscle plasticity in male rats after severe spinal cord injury","volume":"98","author":"Yarrow","year":"2020","journal-title":"J\u00a0Neurosci Res"},{"key":"10.1016\/j.coph.2021.07.023_bib29","doi-asserted-by":"crossref","first-page":"115825","DOI":"10.1016\/j.bone.2020.115825","article-title":"Electrical stimulation of hindlimb skeletal muscle has beneficial effects on sublesional bone in a rat model of spinal cord injury","volume":"144","author":"Zhao","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.coph.2021.07.023_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194440","article-title":"Effects of pharmacologic sclerostin inhibition or testosterone administration on soleus muscle atrophy in rodents after spinal cord injury","volume":"13","author":"Phillips","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.coph.2021.07.023_bib31","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1089\/neu.2011.2203","article-title":"Nandrolone normalizes determinants of muscle mass and fiber type after spinal cord injury","volume":"29","author":"Wu","year":"2012","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.coph.2021.07.023_bib32","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1089\/neu.2016.4814","article-title":"Testosterone plus finasteride prevents bone loss without prostate growth in a rodent spinal cord injury model","volume":"34","author":"Yarrow","year":"2017","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.coph.2021.07.023_bib33","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.biocel.2013.06.025","article-title":"beta2-Adrenergic agonists and the treatment of skeletal muscle wasting disorders","volume":"45","author":"Joassard","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.coph.2021.07.023_bib34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0003-9993(95)80043-3","article-title":"Increased muscle strength in paralyzed patients after spinal cord injury: effect of beta-2 adrenergic agonist","volume":"76","author":"Signorile","year":"1995","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.coph.2021.07.023_bib35","first-page":"981254","article-title":"Randomized, double-blind, and placebo-controlled trial of clenbuterol in denervated muscle atrophy","volume":"2011","author":"Jiang","year":"2011","journal-title":"ISRN Pharm"},{"key":"10.1016\/j.coph.2021.07.023_bib36","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1089\/neu.2009.1211","article-title":"Effects of co-administration of clenbuterol and testosterone propionate on skeletal muscle in paraplegic mice","volume":"27","author":"Ung","year":"2010","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.coph.2021.07.023_sref37","doi-asserted-by":"crossref","first-page":"115366","DOI":"10.1016\/j.taap.2020.115366","article-title":"Time-to-treatment window and cross-sex potential of beta2-adrenergic receptor-induced mitochondrial biogenesis-mediated recovery after spinal cord injury","volume":"411","author":"Scholpa","year":"2021","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.coph.2021.07.023_bib38","first-page":"131","article-title":"Targeting the myostatin signaling pathway to treat muscle loss and metabolic dysfunction","author":"Lee","year":"2021","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.coph.2021.07.023_bib39","article-title":"Low force contractions induce fatigue consistent with muscle mRNA expression in people with spinal cord injury","volume":"2","author":"Petrie","year":"2014","journal-title":"Phys Rep"},{"key":"10.1016\/j.coph.2021.07.023_bib40","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1089\/neu.2015.4058","article-title":"A\u00a0soluble activin receptor IIB fails to prevent muscle atrophy in a mouse model of spinal cord injury","volume":"33","author":"Graham","year":"2016","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.coph.2021.07.023_bib41","first-page":"471","article-title":"Denervation atrophy is independent from Akt and mTOR activation and is not rescued by myostatin inhibition","volume":"7","author":"MacDonald","year":"2014","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.coph.2021.07.023_bib42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.abb.2018.11.005","article-title":"Mitochondrial dysfunction induces muscle atrophy during prolonged inactivity: a review of the causes and effects","volume":"662","author":"Hyatt","year":"2019","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.coph.2021.07.023_bib43","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1159\/000484919","article-title":"Mitochondria targeted peptide attenuates mitochondrial dysfunction, controls inflammation and protects against spinal cord injury-induced lung injury","volume":"44","author":"Zhu","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.coph.2021.07.023_bib44","article-title":"A\u00a050 kdyne contusion spinal cord injury with or without the drug SS-31 was not associated with major changes in muscle mass or gene expression 14 d after injury in young male mice","volume":"9","author":"Graham","year":"2021","journal-title":"Phys Rep"},{"key":"10.1016\/j.coph.2021.07.023_bib45","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.cmet.2011.03.020","article-title":"mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass","volume":"13","author":"Kunkel","year":"2011","journal-title":"Cell Metabol"},{"key":"10.1016\/j.coph.2021.07.023_bib46","first-page":"263","article-title":"Use of mRNA expression signatures to discover small molecule inhibitors of skeletal muscle atrophy","volume":"18","author":"Adams","year":"2015","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.coph.2021.07.023_bib47","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/10408398.2018.1549534","article-title":"Catechins enhance skeletal muscle performance","volume":"60","author":"Li","year":"2020","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.coph.2021.07.023_sref48","doi-asserted-by":"crossref","first-page":"8975","DOI":"10.1007\/s11033-020-05954-x","article-title":"(-)-Epicatechin reduces muscle waste after complete spinal cord transection in a murine model: role of ubiquitin-proteasome system","volume":"47","author":"Gonzalez-Ruiz","year":"2020","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.coph.2021.07.023_bib49","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1002\/med.21717","article-title":"Therapeutic potential of phenylethanoid glycosides: a systematic review","volume":"40","author":"Wu","year":"2020","journal-title":"Med Res Rev"},{"key":"10.1016\/j.coph.2021.07.023_bib50","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1089\/neu.2018.6000","article-title":"Acteoside improves muscle atrophy and motor function by inducing new myokine secretion in chronic spinal cord injury","volume":"36","author":"Kodani","year":"2019","journal-title":"J\u00a0Neurotrauma"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489221001223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489221001223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:55:15Z","timestamp":1761461715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489221001223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":50,"alternative-id":["S1471489221001223"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2021.07.023","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologic approaches to prevent skeletal muscle atrophy after spinal cord injury","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2021.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}